Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
Journal of Visualized Experiments · 2025
DOI: 10.3791/68032 ↗At a glance
Video/Audio in Journal of Visualized Experiments, 2025. Written by Deqiang Han and 4 co-authors. Institution: Cell Therapy Center, Beijing Municipal Geriatric Medical Research Center, Xuanwu Hospital Capital Medical University; National Clinical Research Cent…. Major MEDLINE topics: Stem Cell Transplantation, Parkinson Disease, Neurodegenerative Diseases. 21 references.
Abstract (original language)
The integration of designer receptors exclusively activated by designer drugs (DREADD) with stem cell-based therapies presents an advanced strategy for precise neuronal modulation. Here, we utilized CRISPR-engineered human reprogrammed stem cells expressing excitatory (hM3Dq) or inhibitory (hM4Di) DREADD receptors to evaluate the functional integration and modulation of transplanted dopaminergic precursors in a murine model of Parkinson's disease (PD). Key steps included generating non-fusion DREADD-expressing stem cell lines, differentiating them into midbrain dopaminergic precursors, and transplanting these cells into the striatum of 6-hydroxydopamine (6-OHDA)-lesioned mice. We conducted behavioral assessments and electrophysiological recordings to analyze the effects of the transplanted cells. Behavioral tests, such as the cylinder test, demonstrated significant modulation of motor function following clozapine-N-oxide (CNO) administration. Specifically, activation of hM4Di reduced contralateral forelimb movement, whereas activation of hM3Dq was associated with enhanced motor behavior. Electrophysiological recordings revealed distinct synaptic responses. hM4Di activation increased interevent intervals and decreased peak amplitudes of spontaneous excitatory postsynaptic currents (sEPSCs), whereas hM3Dq activation decreased interevent intervals and increased peak amplitudes, reflecting enhanced excitatory signaling. In summary, the integration of behavioral and electrophysiological assessments validates the precise functional incorporation of engineered chemically reprogrammed stem cells into host neural circuits.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Cell Therapy Center, Beijing Municipal Geriatric Medical Research Center, Xuanwu Hospital Capital Medical University; National Clinical Research Center for Geriatric Diseases, and Key Laboratory of Neurodegenerative Dis…
- The Department of Neurology, Xuanwu Hospital Capital Medical University.
Cite
APA
Han, D., Wang, X., Pan, N., Jing, S., & Chen, Z. (2025). Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases. Journal of Visualized Experiments. https://doi.org/10.3791/68032
Vancouver
Han D, Wang X, Pan N, Jing S, Chen Z. Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases. Journal of Visualized Experiments. 2025. doi:10.3791/68032
BibTeX
@article{Han2025,
author = {Han, Deqiang and Wang, Xueyao and Pan, Na and Jing, Shuili and Chen, Zhiguo},
title = {Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases},
journal = {Journal of Visualized Experiments},
year = {2025},
doi = {10.3791/68032}
}
EUVIMED